Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: Results of a phase III multicenter, double-blind placebo-controlled trial

Copolymer 1 Multiple Sclerosis Study Group

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1268-1276
Number of pages9
JournalNeurology
Volume45
Issue number7
DOIs
StatePublished - Jul 1995

ASJC Scopus Subject Areas

  • Clinical Neurology

Cite this